The treatment of Cervical Dysplasia & High Blood Pressure with vitamins

Cervical Dysplasia and High Blood Pressure: Mitamins custom make quality formulas for the treatment of Cervical Dysplasia & High Blood Pressure with vitamins. A Cervical Dysplasia & High Blood Pressure formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cervical Dysplasia and High Blood Pressure

  • Amount Per Serving
    % DV
    Vitamin A
    10000
    IU
    200%
    Vitamin C
    500
    mg
    833%
    Vitamin E
    200
    IU
    667%
    Folate
    400
    mcg
    100%
    Vitamin B12
    125
    mcg
    2083%
    CoQ-10
    60
    mg
    *
    Flax Seed Powder
    50
    mg
    *
  • Amount Per Serving
    % DV
    Lycopene
    6000
    mcg
    *
    Garlic Extract
    50
    mg
    *
    Green Tea Extract
    600
    mg
    *
    Hawthorn Extract
    100
    mg
    *
    Reishi Extract
    50
    mg
    *
    Taurine
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cervical Dysplasia and High Blood Pressure
Serving Size:4-5

Cervical Dysplasia and High Blood Pressure Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Erectile Dysfunction: A Harbinger of Heart Trouble (HealthDay)
Few men may realize it, but if they're having problems achieving or sustaining erections, it may signal underlying heart trouble.
InterMune Announces Start Of Phase 1b Trial Of ITMN-191
InterMune, Inc. (Nasdaq: ITMN) announced that the company has begun dosing the first patients in their Phase 1b multiple ascending dose (MAD) clinical trial evaluating ITMN-191 (also called R7227) in patients with chronic hepatitis C. ITMN-191 is a hepatitis C virus (HCV) protease inhibitor in development by InterMune and its partner, Roche. InterMune also reported additional information from its recently completed Phase 1a clinical trial of ITMN-191.
This information concerning the support of Cervical Dysplasia and High Blood Pressure treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments